Myasthenia Gravis Treatment Market: Information by Type (Ocular MG, Congenital MG, Transient Neonatal MG), Treatment (Autologous HSCT, Surgery), End-User, Regional Outlook—Forecast Till 2026

May 14, 2019   Global Statistics Representing Myasthenia Gravis Treatment Market Scenario According to the Myasthenia Gravis Foundation of America, myasthenia gravis is one of the most common primary disorders of neuromuscular transmission. Around 14 to 20 out of every 100,000 people in the United States suffer from myasthenia gravis. While myasthenia gravis can affect people of all ages, it is more common in women under 40 and men older than 60. According to Elsevier, 1,283 New Zealanders are affected by a n...
Request Free Sample Report

Tables and figures

LIST OF TABLES

TABLE 1          Global Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 2          Ocular MG Human Myasthenia Gravis Treatment Market Share by Region, 2016–2026 ($Million)

TABLE 3          Congenital MG Myasthenia Gravis Treatment Market Share by Region, 2016–2026 ($Million)

TABLE 4          Global Myasthenia Gravis Treatment Market Share by Treatment, 2016–2026 ($Million)

TABLE 5          Global Myasthenia Gravis Treatment Market by Region, 2016–2026 ($Million)

TABLE 6          Global Myasthenia Gravis Treatment Market Share Value, 2016–2026 ($Million)

TABLE 7          America Myasthenia Gravis Treatment Market Share Value by Country, 2016–2026 ($Million)

TABLE 8          America Myasthenia Gravis Treatment Market Share Value by Type, 2016–2026 ($Million)

TABLE 9          America Myasthenia Gravis Treatment Market Share value, Treatment, 2016–2026 ($Million)

TABLE 10         U.S. Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 11         U.S. Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 12         Canada Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 13         Canada Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 14         Mexico Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 15         Mexico Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 16         Latin America Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 17         Latin America Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 18         Europe Myasthenia Gravis Treatment Market Share Value by Country, 2016–2026 ($Million)

TABLE 19         Europe Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 20         Europe Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 21         Germany Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 22         Germany Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 23         France Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 24         France Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 25         U.K. Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 26         U.K. Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 27         Italy Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 28         Italy Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 30         Spain Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 31         Spain Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 32         Rest of Europe Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 33         Rest of Europe Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 34         Asia-Pacific Myasthenia Gravis Treatment Market Share Value by Country, 2016–2026 ($Million)

TABLE 35         Asia-Pacific Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 36         Asia-Pacific Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 37         Japan Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 38         Japan Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 39         China Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 40         China Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 41         Australia Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 42         Australia Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 43         India Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 44         India Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 45         South Korea Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 46         South Korea Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 47         Rest of Asia-Pacific Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 48         Rest of Asia-Pacific Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 49         LAMEA Myasthenia Gravis Treatment Market Share Value by Country, 2016–2026 ($Million)

TABLE 50         LAMEA Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 51         LAMEA Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 52         Saudi Arabia Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 53         Saudi Arabia Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 54         South Africa Myasthenia Gravis Treatment Market Share, Type, 2016–2026 ($Million)

TABLE 55         South Africa Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 56         Brazil Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 57         Brazil Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

TABLE 58         Rest of LAMEA Myasthenia Gravis Treatment Market Share by Type, 2016–2026 ($Million)

TABLE 59         Rest of LAMEA Myasthenia Gravis Treatment Market Share, Treatment, 2016–2026 ($Million)

LIST OF FIGURES

FIGURE 1         Global Myasthenia Gravis Treatment Market Overview

FIGURE 2         Value Chain Analysis

FIGURE 3         Bargaining Power of Suppliers

FIGURE 4         Bargaining Power of Buyers

FIGURE 5         Threat of Substitutes

FIGURE 6         Threat of New Entrants

FIGURE 7         Competitive Rivalry

FIGURE 8         Myasthenia Gravis Treatment Market, Market Share Analysis, 2018

FIGURE 9         Global Myasthenia Gravis Treatment Market, 2016–2026

FIGURE 10       U.S. Myasthenia Gravis Treatment Market Share, 2016–2026 ($Million)

FIGURE 11       Canada Myasthenia Gravis Treatment Market Share, 2016–2026 ($Million)

FIGURE 12       Mexico Myasthenia Gravis Treatment Market Share, 2016–2026 ($Million)

FIGURE 13       Germany Myasthenia Gravis Treatment Market Share, 2016–2026 ($Million)

FIGURE 14       France Myasthenia Gravis Treatment Market Share, 2016–2026 ($Million)

FIGURE 15       U.K. Myasthenia Gravis Treatment Market Share, 2016–2026 ($Million)

FIGURE 16       Italy Myasthenia Gravis Treatment Market Share, 2016–2026 ($Million)

FIGURE 17       Spain Myasthenia Gravis Treatment Market Share, 2016–2026 ($Million)

FIGURE 18       Rest of Europe Myasthenia Gravis Treatment Market Share, 2016–2026 ($Million)

FIGURE 19       Japan Myasthenia Gravis Treatment Market Share, 2016–2026 ($Million)

FIGURE 20       China Myasthenia Gravis Treatment Market Share, 2016–2026 ($Million)

FIGURE 21       Australia Myasthenia Gravis Treatment Market Share, 2016–2026 ($Million)

FIGURE 22       India Myasthenia Gravis Treatment Market Share, 2016–2026 ($Million)

FIGURE 23       South Korea Myasthenia Gravis Treatment Market Share, 2016–2026 ($Million)

FIGURE 24       Rest of Asia-Pacific Myasthenia Gravis Treatment Market Share, 2016–2026 ($Million)

FIGURE 25       Saudi Arabia Myasthenia Gravis Treatment Market Share, 2016–2026 ($Million)

FIGURE 26       South Africa Myasthenia Gravis Treatment Market Share, 2016–2026 ($Million)

FIGURE 27       Brazil Myasthenia Gravis Treatment Market Share, 2016–2026 ($Million)

FIGURE 28       Rest of LAMEA Myasthenia Gravis Treatment Market Share, 2016–2026 ($Million)

FIGURE 29       Valeant Pharmaceuticals International: Revenue Analysis, ($ million)

FIGURE 30       Valeant Pharmaceuticals International: Segment Revenue 2017 (%)